1. A phase 1, randomized, placebo‐controlled, dose‐escalation study of an anti‐IL‐13 monoclonal antibody in healthy subjects and mild asthmatics. (14th December 2012) Authors: Hodsman, Peter; Ashman, Claire; Cahn, Anthony; De Boever, Erika; Locantore, Nicholas; Serone, Adrian; Pouliquen, Isabelle Journal: British journal of clinical pharmacology Issue: Volume 75:Number 1(2013:Jan.) Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Intravenous pharmacokinetics, local tolerability, and hemolysis of an SBE7‐β‐cyclodextrin formulation of the neurokinin‐1 receptor antagonist vestipitant. Issue 2 (26th May 2014) Authors: Brigandi, Richard A.; Russ, Steven F.; Petit, Chantal; Johnson, Brendan; Croy, Scott; Hodsman, Peter; Muller, Fran Journal: Clinical pharmacology in drug development Issue: Volume 4:Issue 2(2015:Mar./Apr.) Page Start: 130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pharmacokinetics and Pharmacodynamics of the BACE1 Inhibitor Verubecestat (MK‐8931) in Healthy Japanese Adults: A Randomized, Placebo‐Controlled Study. Issue 5 (18th January 2019) Authors: Chris Min, K.; Dockendorf, Marissa F.; Palcza, John; Tseng, Jack; Ma, Lei; Stone, Julie A.; Kleijn, Huub J.; Hodsman, Peter; Masuo, Kazuko; Tanen, Michael; Troyer, Matthew D.; van Vugt, Marianne; Forman, Mark S. Journal: Clinical pharmacology & therapeutics Issue: Volume 105:Issue 5(2019) Page Start: 1234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗